United States · Funded startup

Who invested in connectRN

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$750Kraised across 1 round since 2023, from 1 source

Latest round
Round, $750KMay 2023
Investors
2
See who backed them

The rounds

  1. May 2023

Founders and team

From the SEC filings it signed: 1 on the team.

  • Ted JeanlozExecutive Officeri

On the board, as filediGeoffrey HarrisIdriz LimajJohn PappajohnJohn YetimogluMichael Jasulavic

Everyone who backed them

Cormorant Asset ManagementPrivate equity1round
Adage Capital ManagementAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list connectRN as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Data Point CapitalVC firmPer its own site
Annox CapitalVC firmPer its own site
MtM MentorsCompanyPer its own site

Quick answers about connectRN

Who invested in connectRN?

connectRN's investors include Cormorant Asset Management and Adage Capital Management.

How much has connectRN raised?

connectRN has raised $750K across 1 round since 2023.

When did connectRN last raise?

connectRN's most recent round was an Undisclosed round of $750K in May 2023.

What was connectRN's biggest round?

Its most recent round, $750K in May 2023, is also its largest on record.

Who backed connectRN first?

connectRN's first round on record, in May 2023, was backed by Cormorant Asset Management and Adage Capital Management.

What stage is connectRN at?

connectRN's latest named round is an Undisclosed round, in May 2023.

Where is connectRN based?

connectRN is based in the United States.

Companies like connectRN

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.